Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies
10.1016/j.jmgm.2017.10.010
Saved in:
Main Authors: | Mirza, SB, Lee, RCH, Chu, JJH, Salmas, RE, Mavromoustakos, T, Durdagi, S |
---|---|
Other Authors: | YONG LOO LIN SCHOOL OF MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/173278 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Antiviral activity of lanatoside C against dengue virus infection
by: Cheung, YY, et al.
Published: (2020) -
Dibromopinocembrin and Dibromopinostrobin Are Potential Anti-Dengue Leads with Mild Animal Toxicity
by: Boonyasuppayakorn, S., et al.
Published: (2021) -
Discovery of safe anti-dengue virus drugs from libraries of FDA-approved drugs and plants through screening against viral RNA-dependent RNA polymerase activity
by: EMELYNE QUEK JIANG LI
Published: (2014) -
Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development
by: Wilder-Smith, A., et al.
Published: (2011) -
Computer-aided drug discovery using Philippine natural products to target DENV NS5 methyltransferase (MTase)
by: Dela Cruz, Malea Corrine Legaspi, et al.
Published: (2024)